Effects of Add-on Fluvastatin Therapy in Patients with Chronic Proteinuric Nephropathy on Dual Renin-Angiotensin System Blockade | Zendy

Piero Ruggenenti | Zendy; Annalisa Perna | Zendy; Marcello Tonelli | Zendy; Giacomina Loriga | Zendy; Nicola Motterlini | Zendy; Nadia Rubis | Zendy; Franca Ledda | Zendy; Stefano Rota | Zendy; Andrea Satta | Zendy; Antonio Granata | Zendy; Giovanni Giorgio Battaglia | Zendy; Francesco Cambareri | Zendy; S. David | Zendy; Flavio Gaspari | Zendy; Nadia Stucchi | Zendy; Sergio Carminati | Zendy; Bogdan EneIordache | Zendy; Paolo Cravedi | Zendy; Giuseppe Remuzzi | Zendy

Open Access

Effects of Add-on Fluvastatin Therapy in Patients with Chronic Proteinuric Nephropathy on Dual Renin-Angiotensin System Blockade

Author(s) -

Piero Ruggenenti,

Annalisa Perna,

Marcello Tonelli,

Giacomina Loriga,

Nicola Motterlini,

Nadia Rubis,

Franca Ledda,

Stefano Rota,

Andrea Satta,

Antonio Granata,

Giovanni Giorgio Battaglia,

Francesco Cambareri,

S. David,

Flavio Gaspari,

Nadia Stucchi,

Sergio Carminati,

Bogdan EneIordache,

Paolo Cravedi,

Giuseppe Remuzzi

Publication year - 2010

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.03380410

Subject(s) - benazepril , medicine , valsartan , proteinuria , urology , endocrinology , angiotensin converting enzyme , kidney disease , ace inhibitor , fluvastatin , pharmacology , kidney , blood pressure , simvastatin

This open, prospective, randomized trial aimed to assess the effects of statins in chronic kidney disease patients on optimized antiproteinuric treatment with combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research